Related Experiment Video
Updated: Jun 30, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
[Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant
Nihal Pişkin1, Deniz Akduman, Hande Aydemir
1Zonguldak Karaelmas Universitesi Tip Fakültesi, infeksiyon Hastaliklari ve Klinik Mikrobiyoloji Anabilim Dali, Zonguldak. nihal_piskin@yahoo.com
Abstract:
Infective endocarditis has variable clinical presentations and may present with rheumatologic manifestations. Infective endocarditis due to high level aminoglycoside resistant enterococci represents a severe therapeutic challenge as none of the currently recommended treatment regimens are bactericidal against these isolates. In this report, a case of infective endocarditis with double aetiology, high level aminoglycoside resistant Enterococcus faecalis together with methicillin-resistant coagulase-negative staphylococci (MR-CNS), presenting with leukocytoclastic vasculitis and rapidly progressive glomerulonephritis, has been presented. A 48-years-old woman was admitted to our hospital with malaise and non-pruritic purpural rush on her lower extremities. On admission she had no fever or leukocytosis. Skin biopsy showed leukocytoclastic vasculitis and steroid therapy was started. On 12th day of admission rapidly progressive glomerulonephritis was diagnosed and she received plasmapheresis and haemodialysis support. Transthoracic echocardiography (TTE) demonstrated 1 x 1.5 cm vegetation on the mitral valve. An initial diagnosis of infective endocarditis was made and empirical treatment with vancomycin and gentamicin was started. All blood cultures yielded high level aminoglycoside resistant E. faecalis and additionally two of them yielded MR-CNS. Vancomycin was administered in combination with high dose ampicillin and repeated blood cultures taken after administration of ampicillin, revealed no growth. The patient remained afebrile, renal functions improved and a repeat TTE done on 20th day of ampicillin therapy showed waning of the vegetation. On 42nd day of treatment repeat TTE showed new vegetation on the mitral valve and severe valve insufficiency, so the patient was scheduled for mitral valve replacement. She was treated for 12 weeks with vancomycin and ampicillin and recovered successfully. In conclusion; infective endocarditis should be considered in the differential diagnosis of leukocytoclastic vasculitis and rapidly progressive glomerulonephritis. Physicians should document their treatment outcomes and experience with high level aminoglycoside resistant enterococcal infective endocarditis, which is a therapeutic challenge, so that the best therapeutic options can be identified.
Insights
Infective endocarditis can mimic rheumatologic conditions. This case highlights a challenging infection with resistant bacteria, successfully treated with ampicillin and vancomycin, emphasizing its role in complex endocarditis.
Area of Science:
- Cardiology
- Nephrology
- Rheumatology
Background:
- Infective endocarditis (IE) presents diverse clinical manifestations, including rheumatologic symptoms.
- High-level aminoglycoside-resistant enterococci (HLARE) pose significant therapeutic challenges in IE management.
Observation:
- A patient presented with leukocytoclastic vasculitis and rapidly progressive glomerulonephritis, initially treated with steroids and plasmapheresis.
- Transthoracic echocardiography revealed mitral valve vegetation, leading to a diagnosis of infective endocarditis.
Findings:
- The patient had a dual infection: HLARE and methicillin-resistant coagulase-negative staphylococci (MR-CNS).
- Treatment with vancomycin and high-dose ampicillin resulted in clinical improvement, resolution of renal dysfunction, and vegetation reduction.
- Despite initial improvement, new vegetation and severe mitral insufficiency necessitated valve replacement surgery.
Implications:
- IE should be considered in patients with unexplained vasculitis and glomerulonephritis.
- Ampicillin in combination with vancomycin demonstrated efficacy against HLARE IE, offering a potential treatment option.
- Further documentation of treatment outcomes for HLARE IE is crucial for optimizing therapeutic strategies.
Related Concept Videos
Endocarditis I: Introduction
Rheumatic Heart Disease I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies